BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21489275)

  • 1. HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.
    Kogan M; Rappaport J
    Retrovirology; 2011 Apr; 8():25. PubMed ID: 21489275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vpr-host interactions during HIV-1 viral life cycle.
    Zhao RY; Li G; Bukrinsky MI
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):216-29. PubMed ID: 21318276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection.
    Wang P; Meng Z; Deng K; Gao Z; Cai J
    Virol J; 2024 Apr; 21(1):97. PubMed ID: 38671522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vpr Functions in Primary CD4
    Vanegas-Torres CA; Schindler M
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis.
    Lubow J; Collins KL
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32726944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4
    Bauby H; Ward CC; Hugh-White R; Swanson CM; Schulz R; Goujon C; Malim MH
    mBio; 2021 Jun; 12(3):e0136921. PubMed ID: 34154423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr.
    Dupont L; Bloor S; Williamson JC; Cuesta SM; Shah R; Teixeira-Silva A; Naamati A; Greenwood EJD; Sarafianos SG; Matheson NJ; Lehner PJ
    Cell Host Microbe; 2021 May; 29(5):792-805.e6. PubMed ID: 33811831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.
    Ong EB; Watanabe N; Saito A; Futamura Y; Abd El Galil KH; Koito A; Najimudin N; Osada H
    J Biol Chem; 2011 Apr; 286(16):14049-56. PubMed ID: 21357691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Preintegration Transcription and Host Antagonism.
    Wu Y
    Curr HIV Res; 2023; 21(3):160-171. PubMed ID: 37345240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review.
    Williams ME; Williams AA; Naudé PJW
    BMC Infect Dis; 2023 Aug; 23(1):512. PubMed ID: 37545000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages.
    Virgilio MC; Ramnani B; Chen T; Disbennett WM; Lubow J; Welch JD; Collins KL
    bioRxiv; 2024 Feb; ():. PubMed ID: 36993393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.
    Mukerjee R; Chang JR; Del Valle L; Bagashev A; Gayed MM; Lyde RB; Hawkins BJ; Brailoiu E; Cohen E; Power C; Azizi SA; Gelman BB; Sawaya BE
    J Biol Chem; 2011 Oct; 286(40):34976-85. PubMed ID: 21816823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadly active zinc finger protein-guided transcriptional activation of HIV-1.
    Scott TA; O'Meally D; Grepo NA; Soemardy C; Lazar DC; Zheng Y; Weinberg MS; Planelles V; Morris KV
    Mol Ther Methods Clin Dev; 2021 Mar; 20():18-29. PubMed ID: 33335944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing.
    Laguette N; Brégnard C; Hue P; Basbous J; Yatim A; Larroque M; Kirchhoff F; Constantinou A; Sobhian B; Benkirane M
    Cell; 2014 Jan; 156(1-2):134-45. PubMed ID: 24412650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV accessory proteins versus host restriction factors.
    Strebel K
    Curr Opin Virol; 2013 Dec; 3(6):692-9. PubMed ID: 24246762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpr-a still "enigmatic multitasker".
    Guenzel CA; Hérate C; Benichou S
    Front Microbiol; 2014; 5():127. PubMed ID: 24744753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.
    Schaller T; Ocwieja KE; Rasaiyaah J; Price AJ; Brady TL; Roth SL; Hué S; Fletcher AJ; Lee K; KewalRamani VN; Noursadeghi M; Jenner RG; James LC; Bushman FD; Towers GJ
    PLoS Pathog; 2011 Dec; 7(12):e1002439. PubMed ID: 22174692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
    Zahoor MA; Xue G; Sato H; Murakami T; Takeshima SN; Aida Y
    PLoS One; 2014; 9(8):e106418. PubMed ID: 25170834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.
    Ambrose Z; Aiken C
    Virology; 2014 Apr; 454-455():371-9. PubMed ID: 24559861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity.
    Matreyek KA; Yücel SS; Li X; Engelman A
    PLoS Pathog; 2013; 9(10):e1003693. PubMed ID: 24130490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.